PATENT CLAIM ANALYSIS

Application Number: 16157618
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "252020"]

Abstract:
The present invention relates to compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein A, L, D, R 1 -R 15 , w, x, y, and z are defined herein. The novel cycloalkyl-linked diheterocycle derivatives that are useful in the treatment of abnormal cell growth, such as cancer, in mammals. The present invention also relates to pharmaceutical compositions containing the compounds and to methods of using the compounds and compositions in the treatment of abnormal cell growth in mammals.

Claim (Index 1):
A compound of structure or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 97.0
- Lexical Diversity: 1.67857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15826027', '14769331', '15693291', '13360063', '10540371']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7900425686592777
- 35 USC 102 Novelty (BERT): 0.558466059398866
- Combined Prediction Score: 0.7668849177332365
- Mean Citation Score: 292.786638
- Max Citation Score: 380.57266
- Similarity Product: 282.2439951742959

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test